Gene · 10769
Papers1,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma. | Endocr Connect | 2024 | 37992487 | PubTator, text mining | PubMed |
| Gene expression signatures of stepwise progression of Hepatocellular Carcinoma. | PLoS One | 2023 | 38157373 | PubTator, text mining | PubMed |
| Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry. | BMJ Open | 2023 | 38110389 | PubTator, text mining | PubMed |
| The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer. | Cell Death Discov | 2023 | 38104139 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| ZNF643/ZFP69B Exerts Oncogenic Properties and Associates with Cell Adhesion and Immune Processes. | Int J Mol Sci | 2023 | 38003570 | PubTator, text mining | PubMed |
| Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy. | Medicine (Baltimore) | 2023 | 37986381 | PubTator, text mining | PubMed |
| Leveraging the Fragment Molecular Orbital Method to Explore the PLK1 Kinase Binding Site and Polo-Box Domain for Potent Small-Molecule Drug Design. | Int J Mol Sci | 2023 | 37958623 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. | Cancers (Basel) | 2023 | 37958442 | PubTator, text mining | PubMed |
| α-Synuclein serine129 phosphorylation - the physiology of pathology. | Mol Neurodegener | 2023 | 37953316 | PubTator, text mining | PubMed |
| The Role of Biochemical Cardiac Markers in Atrial Fibrillation. | J Innov Card Rhythm Manag | 2023 | 37927395 | PubTator, text mining | PubMed |
| Novel insights into the ecDNA formation mechanism involving MSH3 in methotrexate‑resistant human colorectal cancer cells. | Int J Oncol | 2023 | 37888748 | PubTator, text mining | PubMed |
| A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer. | Heliyon | 2023 | 37876438 | PubTator, text mining | PubMed |
| PLK3 facilitates replication of swine influenza virus by phosphorylating viral NP protein. | Emerg Microbes Infect | 2023 | 37874309 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Zinc chloride-catalyzed cyclizative 1,2-rearrangement enables facile access to morpholinones bearing aza-quaternary carbons. | Commun Chem | 2023 | 37805578 | PubTator, text mining | PubMed |
| Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance. | Front Endocrinol (Lausanne) | 2023 | 37795356 | PubTator, text mining | PubMed |
| Public RNA-seq data-based identification and functional analyses reveal that MXRA5 retains proliferative and migratory abilities of dental pulp stem cells. | Sci Rep | 2023 | 37730838 | PubTator, text mining | PubMed |
| Comparison of two protocols for the generation of iPSC-derived human astrocytes. | Biol Proced Online | 2023 | 37730545 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10769/papers?page=5